{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:21:30Z","timestamp":1787908890187,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"SIFI SpA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40123-026-01391-4","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:38:56Z","timestamp":1778863136000},"page":"2231-2244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 Cases"],"prefix":"10.1007","volume":"15","author":[{"given":"Karl Anders","family":"Knutsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Zazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Pedrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Roszkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinto","family":"Triolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Mencucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Aragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Birattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Bonacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Buzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Coassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Fasolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Gari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Paganoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pederzolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Secchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7697-6059","authenticated-orcid":false,"given":"Vincenzo","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Franch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"1391_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ajo.2009.06.009","volume":"148","author":"JK Dart","year":"2009","unstructured":"Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009;148:487\u201399.","journal-title":"Am J Ophthalmol"},{"key":"1391_CR2","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1136\/bjophthalmol-2018-312544","volume":"102","author":"N Carnt","year":"2018","unstructured":"Carnt N, Hoffman JJMBBS, Verma S, et al. Acanthamoeba keratitis: confirmation of the UK outbreak and a prospective case-control study identifying contributing risk factors. Br J Ophthalmol. 2018;102:1621\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1391_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jtos.2022.04.003","volume":"25","author":"AR Kaufman","year":"2022","unstructured":"Kaufman AR, Tu EY. Advances in the management of Acanthamoeba keratitis: a review of the literature and synthesized algorithmic approach. Ocul Surf. 2022;25:26\u201336.","journal-title":"Ocul Surf"},{"key":"1391_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12040758","volume":"12","author":"F Petrillo","year":"2024","unstructured":"Petrillo F, Tortori A, Vallino V, et al. Understanding Acanthamoeba keratitis: an in-depth review of a sight-threatening eye infection. Microorganisms. 2024;12:758. https:\/\/doi.org\/10.3390\/microorganisms12040758.","journal-title":"Microorganisms"},{"key":"1391_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ophtha.2024.08.003","volume":"132","author":"F Aiello","year":"2025","unstructured":"Aiello F, Gallo Afflitto G, et al. Perspectives on the incidence of Acanthamoeba keratitis: a systematic review and meta-analysis. Ophthalmology. 2025;132:206\u201321.","journal-title":"Ophthalmology"},{"key":"1391_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/bjo.86.5.536","volume":"86","author":"CF Radford","year":"2002","unstructured":"Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol. 2002;86:536\u201342.","journal-title":"Br J Ophthalmol"},{"key":"1391_CR7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1017\/S0031182012000042","volume":"139","author":"R Siddiqui","year":"2012","unstructured":"Siddiqui R, Dudley R, Khan NA. Acanthamoeba differentiation: a two-faced drama of Dr Jekyll and Mr Hyde. Parasitology. 2012;139:826\u201334. https:\/\/doi.org\/10.1017\/S0031182012000042.","journal-title":"Parasitology"},{"key":"1391_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/opo.12752","volume":"41","author":"AG de Lacerda","year":"2020","unstructured":"de Lacerda AG, Lira M. Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology. Ophthalmic Physiol Opt. 2020;41:116\u201335. https:\/\/doi.org\/10.1111\/opo.12752.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1391_CR9","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.ophtha.2008.04.038","volume":"115","author":"EY Tu","year":"2008","unstructured":"Tu EY, Joslin CE, Sugar J, et al. Prognostic factors affecting visual outcome in Acanthamoeba keratitis. Ophthalmology. 2008;115:1998\u20132003.","journal-title":"Ophthalmology"},{"key":"1391_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoint.2024.100095","volume":"2","author":"GM Salgado","year":"2025","unstructured":"Salgado GM, Ribeiro JD, Perez-Vivas JA, et al. Clinical and management factors linked to good visual outcomes in Acanthamoeba keratitis: a systematic review and meta-analysis. AJO Int. 2025;2:100095.","journal-title":"AJO Int"},{"key":"1391_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/02713683.2020.1846753","volume":"46","author":"S Bonini","year":"2021","unstructured":"Bonini S, Di Zazzo A, Varacalli G, Coassin M. Acanthamoeba keratitis: perspectives for patients. Curr Eye Res. 2021;46:771\u20136.","journal-title":"Curr Eye Res"},{"key":"1391_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13162655","volume":"13","author":"M Azzopardi","year":"2023","unstructured":"Azzopardi M, Chong YJ, Ng B, et al. Diagnosis of Acanthamoeba keratitis: past, present and future. Diagnostics Basel. 2023;13:2655. https:\/\/doi.org\/10.3390\/diagnostics13162655. (PMID: 37627913; PMCID: PMC10453105).","journal-title":"Diagnostics Basel"},{"key":"1391_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ICO.0b013e31820f7763","volume":"30","author":"CE Oldenburg","year":"2011","unstructured":"Oldenburg CE, Acharya NR, Tu EY, et al. Practice patterns and opinions in the treatment of Acanthamoeba keratitis. Cornea. 2011;30:1363\u20138.","journal-title":"Cornea"},{"key":"1391_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/ICO.0000000000002880","volume":"41","author":"A Di Zazzo","year":"2022","unstructured":"Di Zazzo A, Varacalli G, De Gregorio C, Coassin M, Bonini S. Therapeutic corneal transplantation in Acanthamoeba keratitis: penetrating versus lamellar keratoplasty. Cornea. 2022;41:396\u2013401.","journal-title":"Cornea"},{"key":"1391_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.survophthal.2016.10.009","volume":"62","author":"LC Carrijo-Carvalho","year":"2017","unstructured":"Carrijo-Carvalho LC, Sant\u2019ana VP, Foronda AS, et al. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus. Surv Ophthalmol. 2017;62:203\u201318.","journal-title":"Surv Ophthalmol"},{"key":"1391_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000334270","volume":"2","author":"G Ferrari","year":"2011","unstructured":"Ferrari G, Matuska S, Rama P. Double-biguanide therapy for resistant Acanthamoeba keratitis. Case Rep Ophthalmol. 2011;2:338\u201342.","journal-title":"Case Rep Ophthalmol"},{"key":"1391_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bjophthalmol-2019-314485","volume":"104","author":"V Papa","year":"2020","unstructured":"Papa V, Rama P, Radford C, et al. Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases. Br J Ophthalmol. 2020;104:575\u201381.","journal-title":"Br J Ophthalmol"},{"key":"1391_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222092","volume":"14","author":"AC Randag","year":"2019","unstructured":"Randag AC, van Rooij J, van Goor AT, et al. The rising incidence of Acanthamoeba keratitis: a 7-year nationwide survey and clinical assessment of risk factors and functional outcomes. PLoS ONE. 2019;14:e0222092. https:\/\/doi.org\/10.1371\/journal.pone.0222092.","journal-title":"PLoS ONE"},{"key":"1391_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ophtha.2014.07.052","volume":"122","author":"D Robaei","year":"2015","unstructured":"Robaei D, Carnt N, Minassian DC, et al. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology. 2015;122:17\u201324.","journal-title":"Ophthalmology"},{"key":"1391_CR20","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.survophthal.2024.06.001","volume":"69","author":"M Posarelli","year":"2024","unstructured":"Posarelli M, Passaro ML, Avolio FC, et al. The incidence of severe complications in Acanthamoeba keratitis: qualitative and quantitative systematic assessment. Surv Ophthalmol. 2024;69:769\u201378.","journal-title":"Surv Ophthalmol"},{"key":"1391_CR21","doi-asserted-by":"crossref","unstructured":"Dart JKG, Papa V, Rama P, et al. The orphan drug for Acanthamoeba keratitis (ODAK) trial: PHMB 0.08% (Polihexanide) and placebo versus PHMB 0.02% and propamidine 0.1. Ophthalmology. 2024;131:277\u2013287.","DOI":"10.1016\/j.ophtha.2023.09.031"},{"key":"1391_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/ICL.0000000000001092","volume":"50","author":"A Di Zazzo","year":"2024","unstructured":"Di Zazzo A, De Gregorio C, Coassin M. Novel effective medical therapy for Acanthamoeba keratitis. Eye Contact Lens. 2024;50:279\u201381.","journal-title":"Eye Contact Lens"},{"key":"1391_CR23","doi-asserted-by":"crossref","unstructured":"Franch A, Knutsson KA, Pedrotti E, et al. Treatment of\u00a0Acanthamoeba\u00a0keratitis with high dose PHMB (0.08%) monotherapy in clinical practice: A case series. Eur J Ophthalmol. 2025,35:1235\u201341.","DOI":"10.1177\/11206721241299470"},{"key":"1391_CR24","doi-asserted-by":"publisher","unstructured":"Kuzman, T. Mati\u0107, S. Gabri\u0107, I. et al. Successful treatment of Acanthamoeba keratitis according to new protocol with polihexanide 0.08% therapy: case report.\u00a0Reports. 2025;8:44. https:\/\/doi.org\/10.3390\/reports802004.","DOI":"10.3390\/reports802004"},{"key":"1391_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ophtha.2014.01.031","volume":"12","author":"D Robaei","year":"2014","unstructured":"Robaei D, Carnt N, Minassian DC, et al. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis. Ophthalmology. 2014;12:1383\u20138.","journal-title":"Ophthalmology"},{"key":"1391_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0886-3350(01)01077-X","volume":"28","author":"V Papa","year":"2002","unstructured":"Papa V, Milazzo G, Santocono M, et al. Naproxen ophthalmic solution to manage inflammation after phacoemulsification. J Cataract Refract Surg. 2002;28:321\u20137.","journal-title":"J Cataract Refract Surg"},{"key":"1391_CR27","doi-asserted-by":"publisher","first-page":"e963","DOI":"10.1111\/aos.14659","volume":"99","author":"G Moussa","year":"2021","unstructured":"Moussa G, Bassilious K, Mathews N. A novel Excel sheet conversion tool from Snellen fraction to LogMAR including \u201ccounting fingers\u201d, \u201chand movement\u201d, \u201clight perception\u201d and \u201cno light perception\u201d and focused review of literature of low visual acuity reference values. Acta Ophthalmol. 2021;99:e963\u20135.","journal-title":"Acta Ophthalmol"},{"key":"1391_CR28","doi-asserted-by":"crossref","unstructured":"Day AC, Donachie PH, Sparrow JM, et al. Royal college of ophthalmologists\u2019 national ophthalmology database. The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015;29:552\u201360.","DOI":"10.1038\/eye.2015.3"},{"key":"1391_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jtos.2025.03.008","volume":"38","author":"JKG Dart","year":"2025","unstructured":"Dart JKG, Papa V, Rama P, et al. Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician\u2019s individualised treatment. Ocul Surf. 2025;38:132\u201341.","journal-title":"Ocul Surf"},{"key":"1391_CR30","unstructured":"Moschetti V, Papa V, Sudano A, Spina D, Abbate I. Formulation based on polyhexamethylene biguanide for use in the treatment of Acanthamoeba keratitis and\/or fungal infections. WIPO\/PCT Patent WO 2022\/101821\/A1"},{"issue":"2","key":"1391_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264021","volume":"17","author":"CA Moe","year":"2022","unstructured":"Moe CA, Lalitha P, Prajna NV, et al. Outcomes of amoebic, fungal, and bacterial keratitis: a retrospective cohort study. PLoS ONE. 2022;17(2):e0264021. https:\/\/doi.org\/10.1371\/journal.pone.0264021.","journal-title":"PLoS ONE"},{"key":"1391_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/life15060933","volume":"15","author":"L Fu","year":"2025","unstructured":"Fu L, Wasielica-Poslednik J, Geerling G, et al. Navigating the challenges of Acanthamoeba keratitis: current trends and future directions. Life. 2025;15:933. https:\/\/doi.org\/10.3390\/life15060933.","journal-title":"Life"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01391-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01391-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01391-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:23:38Z","timestamp":1782739418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01391-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1391"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01391-4","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Vincenzo Papa is an employee of SIFI SpA (Italy). Karl Anders Knutsson, Antonio Di Zazzo, Emilio Pedrotti, Paolo Rama, Vito Romano, Anna Maria Roszkowska, Giacinto Triolo, Francesco Aiello, Stefano De Angelis, Rita Mencucci, Pasquale Aragona, Federica Birattari, Erika Bonacci, Matilde Buzzi, Marco Coassin, Adriano Fasolo, Mariangela Gari, Pia Leon, Carlo Nucci, Giorgio Paganoni, Matteo Pederzolli, Fabiana Secchi, Sabrina Vaccaro and Antonella Franch have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the CET 1 Comitato Etico Regione Lombardia 1 of the coordinating center (San Raffaele Scientific Institute, Milan, Italy) on April 24, 2024 (approval number CET 148\/2024). The study was performed in accordance with the Helsinki Declaration of 1964 and later amendments. Written informed consent was obtained from all patients prior to the commencement of the study, including consent to the use of their clinical data for scientific purposes. Identifying characteristics within the data were replaced with a pseudonym, which does not allow the data subject to be directly identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}